Serum thymidine kinase activity in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with palbociclib and fulvestrant
Collections
Research team
Clinical Trials & Statistics Unit
Language
eng
Date accepted
2022-01-11
License start date
2022-01-11
Citation
European Journal of Cancer
Publisher
Elsevier